Serveur d'exploration MERS - Exploration (Accueil)

Index « AbsEn.i » - entrée « several »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
seventy < several < severe  Facettes :

List of bibliographic references indexed by several

Number of relevant bibliographic references: 675.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000009 (2020) B. Du [République populaire de Chine] ; H B Qiu [République populaire de Chine] ; X. Zhan [République populaire de Chine] ; Y S Wang [République populaire de Chine] ; H Y J. Kang [République populaire de Chine] ; X Y Li [République populaire de Chine] ; F. Wang [République populaire de Chine] ; B. Sun [République populaire de Chine] ; Z H Tong [République populaire de Chine][Pharmacotherapeutics for the New Coronavirus Pneumonia].
000018 (2020) Akihiro Shigeno ; Takeshi Hiu ; Hiroshi Iwanaga ; Tadateru Yasu ; Ryoko Honda ; Kenjiro Nakaoka ; Yutaka Fukuda ; Tomonori Ono ; Ichiro Kawahara ; Wataru Haraguchi ; Ryujiro Ushijima ; Keisuke Tsutsumi[A Pediatric Case of Clinically Mild Encephalitis/Encephalopathy with a Reversible Splenial Lesion(MERS)with Recurrent TIA-like Symptoms over a Prolonged Period].
000020 (2020) Caroline Lacault [France] ; Martial Briand [France] ; Marie-Agnès Jacques [France] ; Armelle Darrasse [France]Zucchini Vein Clearing Disease Is Caused by Several Lineages Within Pseudomonas syringae Species Complex.
000040 (2020) Chang Hoon Yang ; Hyejin JungTopological dynamics of the 2015 South Korea MERS-CoV spread-on-contact networks
000041 (2020) Sean Ekins [Oman] ; Peter B. Madrid [États-Unis]Tilorone: A Broad-Spectrum Antiviral For Emerging Viruses.
000044 (2020) Yan-Rong Guo ; Qing-Dong Cao ; Zhong-Si Hong ; Yuan-Yang Tan ; Shou-Deng Chen ; Hong-Jun Jin ; Kai-Sen Tan [Singapour] ; De-Yun Wang [Singapour] ; Yan YanThe origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status
000052 (2020) S Nia Garcia [Espagne] ; Jonathan F. Wendel [États-Unis] ; Natalia Borowska-Zuchowska [Pologne] ; Malika Aïnouche [France] ; Alena Kuderova ; Ales KovarikThe Utility of Graph Clustering of 5S Ribosomal DNA Homoeologs in Plant Allopolyploids, Homoploid Hybrids, and Cryptic Introgressants
000066 (2020) Naidi Yang [République populaire de Chine] ; Han-Ming Shen [République populaire de Chine]Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19
000067 (2020) Nathan Ford [Suisse] ; Marco Vitoria [Suisse] ; Ajay Rangaraj [Suisse] ; Susan L. Norris [Suisse] ; Alexandra Calmy [Suisse] ; Meg Doherty [Suisse]Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID-19: initial assessment.
000088 (2020) Janko Nikolich-Zugich [États-Unis] ; Kenneth S. Knox [États-Unis] ; Carlos Tafich Rios [États-Unis] ; Bhupinder Natt [États-Unis] ; Deepta Bhattacharya [États-Unis] ; Mindy J. Fain [États-Unis]SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes
000110 (2020) Junxiong Pang [Singapour] ; Min Xian Wang [Singapour] ; Ian Yi Han Ang ; Sharon Hui Xuan Tan ; Ruth Frances Lewis ; Jacinta I-Pei Chen ; Ramona A. Gutierrez ; Sylvia Xiao Wei Gwee [Singapour] ; Pearleen Ee Yong Chua [Singapour] ; Qian Yang ; Xian Yi Ng ; Rowena K. S. Yap ; Hao Yi Tan ; Yik Ying Teo ; Chorh Chuan Tan ; Alex R. Cook ; Jason Chin-Huat Yap ; Li Yang HsuPotential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review
000118 (2020) Balamurugan Shanmugaraj [Thaïlande] ; Konlavat Siriwattananon [Thaïlande] ; Kittikhun Wangkanont [Thaïlande] ; Waranyoo Phoolcharoen [Thaïlande]Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19).
000121 (2020) Jieliang ChenPathogenicity and transmissibility of 2019-nCoV—A quick overview and comparison with other emerging viruses
000129 (2020) Zachary J. Sandler [États-Unis] ; Mason R. Firpo [États-Unis] ; Oreoluwa S. Omoba [États-Unis] ; Michelle N. Vu [États-Unis] ; Vineet D. Menachery [États-Unis] ; Bryan C. Mounce [États-Unis]Novel ionophores active against La Crosse virus identified through rapid antiviral screening.
000142 (2020) Yuan Yuan [République populaire de Chine] ; Jianxun Qi [République populaire de Chine] ; Ruchao Peng [République populaire de Chine] ; Chunrui Li [République populaire de Chine] ; Guangwen Lu [République populaire de Chine] ; Jinghua Yan [République populaire de Chine] ; Qihui Wang [République populaire de Chine] ; George Fu Gao [République populaire de Chine]Molecular Basis of Binding between Middle East Respiratory Syndrome Coronavirus and CD26 from Seven Bat Species.
000143 (2020) Hongchun Li [République populaire de Chine] ; Pemra Doruker [États-Unis] ; Guang Hu [République populaire de Chine] ; Ivet Bahar [États-Unis]Modulation of Toroidal Proteins Dynamics in Favor of Functional Mechanisms upon Ligand Binding.
000161 (2020) Anwar E. Ahmed [États-Unis]Limited transmissibility of coronavirus (SARS-1, MERS, and SARS-2) in certain regions of Africa.
000162 (2020) Ying Yan [République populaire de Chine] ; Le Chang [République populaire de Chine] ; Lunan Wang [République populaire de Chine]Laboratory testing of SARS-CoV, MERS-CoV, and SARS-CoV-2 (2019-nCoV): Current status, challenges, and countermeasures.
000167 (2020) Hossam M. Ashour [États-Unis] ; Walid F. Elkhatib [Égypte] ; Md Masudur Rahman [Bangladesh] ; Hatem A. Elshabrawy [États-Unis]Insights into the Recent 2019 Novel Coronavirus (SARS-CoV-2) in Light of Past Human Coronavirus Outbreaks.
000170 (2020) Shuai Xia [République populaire de Chine] ; Meiqin Liu [République populaire de Chine] ; Chao Wang [République populaire de Chine] ; Wei Xu [République populaire de Chine] ; Qiaoshuai Lan [République populaire de Chine] ; Siliang Feng [République populaire de Chine] ; Feifei Qi [République populaire de Chine] ; Linlin Bao [République populaire de Chine] ; Lanying Du [États-Unis] ; Shuwen Liu [République populaire de Chine] ; Chuan Qin [République populaire de Chine] ; Fei Sun [République populaire de Chine] ; Zhengli Shi [République populaire de Chine] ; Yun Zhu [République populaire de Chine] ; Shibo Jiang [République populaire de Chine, États-Unis] ; Lu Lu [République populaire de Chine]Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
000184 (2020) Neetha Nanoth Vellichirammal [États-Unis] ; Abrar Albahrani [États-Unis] ; You Li [République populaire de Chine] ; Chittibabu Guda [États-Unis]Identification of Fusion Transcripts from Unaligned RNA-Seq Reads Using ChimeRScope.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "several" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "several" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    several
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021